700+ total transactions representing $120B+ in aggregate value — 10 tracked below spanning 2019–2025 · 3 industries
Chardan acted as sole placement agent for ZOOZ Power's $159 million private placement in connection with adoption of a bitcoin treasury reserve strategy, plus $1 billion ATM program as sales agent.
Chardan acted as exclusive M&A and capital markets advisor on the $1.5 billion pro forma enterprise value SPAC merger. BitFuFu is a cryptocurrency cloud mining service provider backed by Bitmain.
Chardan acted as sole placement agent and exclusive financial advisor on the $888 million reverse merger and PIPE transaction.
Chardan acted as lead M&A and capital markets advisor on the SPAC merger with Immunovant, a clinical-stage biopharmaceutical company focused on autoimmune diseases. Chardan also acted as lead book runner on HSAC's $115 million IPO.
Chardan sponsored the SPAC and acted as M&A and capital markets advisor on the $248 million merger with BiomX, a microbiome company developing phage therapies. The combined company retained more than $60 million in trust at closing.
Chardan acted as exclusive financial advisor on the $305 million reverse merger.
Chardan acted as financial advisor and capital markets advisor on the $2.50 billion SPAC M&A transaction.
Chardan acted as M&A and capital markets advisor on the $1.66 billion SPAC M&A transaction.
Chardan acted as M&A and lead financial advisor on the sale of Neos, a smart home technology provider, from Aviva plc to Sky (Europe's leading media and entertainment company and part of Comcast Corporation).
Chardan acted as lead left book-runner on the oversubscribed $230 million SPAC IPO. This was Chardan's 13th SPAC transaction in 2020 and 81st SPAC IPO since inception. The SPAC targets plant-based food and alternative proteins.